SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-041026
Filing Date
2024-05-09
Accepted
2024-05-09 07:40:17
Documents
15
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea020558401-8k_cormedix.htm   iXBRL 8-K 23416
2 PRESS RELEASE DATED MAY 9, 2024 ea020558401ex99-1_cormedix.htm EX-99.1 44504
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5502
  Complete submission text file 0001213900-24-041026.txt   256860

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crmd-20240509.xsd EX-101.SCH 3024
4 XBRL LABEL FILE crmd-20240509_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE crmd-20240509_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT ea020558401-8k_cormedix_htm.xml XML 3673
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 24928613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)